drugset / Trial / NCT00691665

Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial

NCT00691665

Phase 4 Completed 130 enrolled Alcon Research
RandomizedParallel-groupTriple-blindTreatment

Summary

Comparison of two nasal sprays for the treatment of seasonal allergic rhinitis

Timeline

Start
2008-05
Primary completion
2009-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluticasone propionate Other / unclassified 50 ug Intranasal
Subject Olopatadine Other / unclassified 0.6 % Intranasal